Reducing Alzheimer's disease risk with SGLT2 inhibitors: From glycemic control to neuroprotection. uri icon

authors

  • Alami, Mehdi
  • Morvaridzadeh, Mojgan
  • El Khayari, Abdellatif
  • Boumezough, Kaoutar
  • El Fatimy, Rachid
  • Khalil, Abdelouahed
  • Tamas JR Fulop, MD, PhD
  • Berrougui, Hicham

publication date

  • April 7, 2025